Medpace competitors

Zippia Score 4.5

Medpace main competitors are Parexel International, Novella, and Pharmaceutical Research Associates, Inc.

Competitor Summary. See how Medpace compares to its main competitors:

Covance has the most employees (50,000).
Employees at Parexel International earn more than most of the competitors, with an average yearly salary of $91,480.
The oldest company is Axio Research, founded in 1979.

Work At Medpace?

Share Your Experience

Medpace vs competitors

Company	Founding Date	Zippia Score	Headquarters	# of Locations	Revenue	Employees
M Medpace	1992	4.5	Cincinnati, OH	3	$1.5B	2,800
B Biorasi	2002	4.2	Hollywood, FL	2	$23.0M	750
P Pharmaceutical Research Associates, Inc.	1981	4.6	Reston, VA	1	$30.0M	30
P Parexel International	1983	4.5	Waltham, MA	9	$2.4B	18,900
N Novella	1998	4.2	Morrisville, NC	1	$9.2M	3,000
C ClinForce	1983	3.3	Durham, NC	1	$650,000	10
P Pharmaceutical Product Development	1985	4.1	Wilmington, NC	13	$65.0M	21,000
P Premier Research	1989	4.5	Philadelphia, PA	9	$54.0M	1,001
A Axio Research	1979	3.8	Seattle, WA	1	$5.4M	50
C Covance	1987	4.4	Princeton, NJ	25	$2.6B	50,000

Medpace Competitors Jobs

Medpace Jobs openings vs Similar Companies

If you’re looking for a job, here are the jobs openings at Medpace and its competitors.

Company Name	Jobs Openings	Remote Jobs Openings
M Medpace	602	172
P Pharmaceutical Product Development	1,067	477

Medpace Remote Jobs

Rate Medpace's competitiveness in the market.

Medpace salaries vs Competitors

Among Medpace competitors, employees at Parexel International earn the most with an average yearly salary of $91,480.

Compare Medpace Salaries VS Competitors

Company	Average Salary	Hourly Salary	Salary Score
M Medpace	$69,547	$33.44	-
B Biorasi	$69,796	$33.56	-
P Pharmaceutical Research Associates, Inc.	$77,178	$37.10	-
P Parexel International	$91,480	$43.98	-
N Novella	$77,466	$37.24	-
C ClinForce	$65,025	$31.26	-

Compare Medpace Job Title Salaries VS Competitors

Company	Highest Salary	Hourly Salary
M Medpace	$59,104	$28.42
P Pharmaceutical Research Associates, Inc.	$68,192	$32.78
P Parexel International	$67,932	$32.66
A Axio Research	$66,533	$31.99
N Novella	$65,856	$31.66
P Pharmaceutical Product Development	$59,947	$28.82
B Biorasi	$59,025	$28.38
C ClinForce	$58,996	$28.36
P Premier Research	$58,891	$28.31
C Covance	$57,259	$27.53

Do you work at Medpace?

Does Medpace effectively differentiate itself from competitors?

Medpace Jobs

Medpace demographics vs competitors

Compare Gender At Medpace Vs Competitors

Job Title	Male	Female
Medpace	33%	67%
Parexel International	40%	60%
Covance	42%	58%

Male

Female

100%

75%

50%

25%

Covance

Parexel International

Medpace

25%

50%

75%

100%

Compare Race At Medpace Vs Competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity Score
M Medpace	66%	11%	8%	12%	3%	9.5
P Parexel International	57%	13%	11%	15%	5%	9.8
C Covance	59%	14%	11%	12%	4%	9.9

Medpace REVENUE Vs Competitors

Medpace revenue is $1.5B. Among it's competitors, the company with the highest revenue is Covance, $2.6B . The company with the lowest revenue is ClinForce, $650.0K.

Medpace
Parexel International

Medpace And Similar Companies CEOs

CEOBio

Jamie MacDonald

Parexel International

Jamie Macdonald is Chief Executive Officer of Parexel. He has nearly 25 years of experience in leading global biopharmaceutical services companies. Prior to joining Parexel, Mr. Macdonald served as CEO of INC Research, now known as Syneos Health, from January 2013 through September 2016, where he led the company through a successful Initial Public Offering in 2014. Mr. Macdonald also served as INC’s Chief Operating Officer from July 2011 through December 2012, and previously held several leadership positions in the biopharmaceutical services industry, including Senior Vice President and Head of Global Project Management at Quintiles, now known as IQVIA. Prior to this, he held various senior operational and finance roles at Quintiles. He has previously served on the Board of Directors for the Association of Clinical Research Organizations (ACRO) and as its Chairman in 2015. Mr. Macdonald’s recent experience also includes serving as Chairman of the Board for Certara, a drug development consultancy with solutions spanning discovery, preclinical and clinical drug development, from 2017 to 2018. Mr. Macdonald began his career in the pharmaceutical industry with Syntex Corporation (acquired by Roche Holdings, Inc.). A native of Scotland, he holds a B.A. in Economics from Heriot-Watt University in Edinburgh, Scotland and is a qualified Chartered Management Accountant (ACMA).

Paul Kirchgraber

Covance

Paul Kirchgraber is a CEO at Covance.

Richard Staub

Novella

David Simmons

Pharmaceutical Product Development

Ludo Reynders

Premier Research

Chris O’Brien

Biorasi

Lee Hooks